These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4797742)

  • 1. Parathyroid function in patients with Paget's disease treated with salmon calcitonin.
    Burckhardt PM; Singer FR; Potts JT
    Clin Endocrinol (Oxf); 1973 Jan; 2(1):15-22. PubMed ID: 4797742
    [No Abstract]   [Full Text] [Related]  

  • 2. Parathyroid function during treatment with salmon calcitonin.
    Chapuy MC; David L; Meunier PJ
    Horm Metab Res; 1980 Sep; 12(9):486-7. PubMed ID: 7429419
    [No Abstract]   [Full Text] [Related]  

  • 3. [Parathyroid function in Paget's disease of bone].
    Chapuy MC; Zucchelli P; Meunier PJ
    Rev Rhum Mal Osteoartic; 1982 Feb; 49(2):99-102. PubMed ID: 7063800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Paget's disease with salmon calcitonin].
    Manderlier T; Fuss M; Brauman J; Orloff S; Bergans A; Corvilain J
    Rev Rhum Mal Osteoartic; 1977 Jan; 44(1):59-66. PubMed ID: 319520
    [No Abstract]   [Full Text] [Related]  

  • 5. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC; Meunier P; Terrier M; David L; Vignon G
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. II.
    Kleeman CR; Massry SG; Coburn JW
    Calif Med; 1971 Apr; 114(4):19-30. PubMed ID: 4927915
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of parathyroid hormone, calcitonin and phosphate on bone cells in Paget's disease.
    Bordier P; Rasmussen H; Dorfmann H
    Am J Med; 1974 Jun; 56(6):850-7. PubMed ID: 4831322
    [No Abstract]   [Full Text] [Related]  

  • 8. Parathyroid function in Paget's disease of bone.
    Siris ES; Clemens TP; McMahon D; Gordon A; Jacobs TP; Canfield RE
    J Bone Miner Res; 1989 Feb; 4(1):75-9. PubMed ID: 2718781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Variations in parathormone serum levels during treatment of Paget's disease with calcitonin of human or salmon origin (author's transl)].
    Heynen G; Franchimont P; Gaspar S; Gysen P; Kanis JA
    Ann Endocrinol (Paris); 1981; 42(3):265-75. PubMed ID: 7316460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC; Harrison JE; Wilson DR
    Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of antibodies and clinical resistance to salmon calcitonin.
    Singer FR; Aldred JP; Neer RM; Krane SM; Potts JT; Bloch KJ
    J Clin Invest; 1972 Sep; 51(9):2331-8. PubMed ID: 4674133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
    Avramides A; Baker RK; Wallach S
    Metabolism; 1974 Nov; 23(11):1037-46. PubMed ID: 4472557
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K; Schmidt UJ; Abendroth K; Ansorg H; Graner H; Lindenhayn K; Schramm G; Kalbe I
    Z Alternsforsch; 1978; 33(5):441-51. PubMed ID: 570764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calcium lowering effect of synthetic human, porcine, and salmon calcitonin in patients with Paget's disease.
    Galante L; Joplin GF; MacIntyre I; Woodhouse NJ
    Clin Sci; 1973 Jun; 44(6):605-10. PubMed ID: 4736581
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of physiological and pathological activity of osteoclasts and osteoblasts with special reference to calciotropic hormones: parathyroid hormone, calcitonin and calcitriol].
    Caniggia M
    Clin Ter; 1991 Aug 15-31; 138(3-4):123-57. PubMed ID: 1834407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term therapy with calcitonin in Paget's diseases (author's transl)].
    Schmidt UJ; Trzenschik K; Abendroth K; Graner H; Ansorg A
    Z Alternsforsch; 1978; 33(2):173-83. PubMed ID: 100975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
    Rojanasathit S; Rosenberg E; Haddad JG
    Lancet; 1974 Dec; 2(7894):1412-5. PubMed ID: 4140329
    [No Abstract]   [Full Text] [Related]  

  • 18. [The value of the calcitonin test in Paget's disease of bone].
    D'Amore M; Bozzi A; Telesca ML; Carrozzo M
    Minerva Med; 1981 Apr; 72(14):865-8. PubMed ID: 7219796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive personal experience: Paget's disease of bone.
    Siris ES
    J Clin Endocrinol Metab; 1995 Feb; 80(2):335-8. PubMed ID: 7852484
    [No Abstract]   [Full Text] [Related]  

  • 20. Newer agents in treating Paget's disease of bone.
    Goldfield EB
    Geriatrics; 1974 Dec; 29(12):61-9. PubMed ID: 4279196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.